Bioprotect
BioProtect is an international medical device startup engaged in developing biodegradable balloon spacers for radiation therapy.
Bioprotect has raised €33M across 2 funding rounds, most recently a Series D+ round in Sep 2020. Based in Tsur Moshe, Israel; founded 2004; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€33M
€32,781,821
Funding rounds
2
Investors
0
distinct backers
Active since
2020-01
latest 2020-09
Funding by year
EUR raised per yearBioprotect — funding by year — interactive chart.
Data table
| Bioprotect — funding by year | |
|---|---|
| 2019 | €12M |
| 2020 | €21M |
Signals
Medium confidenceRaise-next likelihood12
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood5
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Old (22y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-22 | Series D+ | €21M | — | View deal → |
| 2020-01-01 | Series D+ | €12M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData